Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion [Yahoo! Finance]
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
MedeAnalytics Appoints Chris Lance as Chief Product Officer [Yahoo! Finance]
Evolent Health (NYSE:EVH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $10.00 price target on the stock, down previously from $16.00.
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $9.50 to $6.00. They now have a "buy" rating on the stock.